Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
VIAVI Solutions (VIAV) Form 4: A company director reported the vesting and settlement of restricted stock units into 6,768 shares of common stock on 11/07/2025. The transaction was coded “M,” indicating a conversion of derivatives, with the shares acquired at $0 per share. Following the transaction, the director beneficially owns 6,768 common shares directly, and holds 0 RSUs. The RSUs convert 1-for-1 into common stock and vest on the earlier of the one-year grant anniversary or the next annual meeting.
VIAVI Solutions (VIAV) disclosed a director’s RSU vesting and settlement. On November 7, 2025, 23,529 restricted stock units converted into an equal number of common shares at $0 per share (code M). No shares were sold in this filing.
Following the transaction, the reporting person directly owns 240,683 common shares. The RSUs vested 100% on November 7, 2025 and, per the disclosure, RSUs have no expiration date.
VIAVI Solutions (VIAV) reported a director transaction on Form 4 tied to an RSU vesting on November 7, 2025. The filing shows 23,529 shares of common stock acquired at $0 under code “M” (conversion of RSUs). After this transaction, the director beneficially owns 148,680 shares, held directly. Each stock unit converted 1-for-1 into common stock, and the RSU award had no expiration, with units vesting 100% on November 7, 2025.
Viavi Solutions (VIAV) reported a Form 4 showing a company director sold common stock in two transactions on 11/04/2025. The director sold 23,050 shares at a weighted average price of $16.98 and 16,950 shares at $17.24, and held 148,524 shares directly after the reported sales.
The first sale was executed in multiple trades within a price range of $16.97–$17.03, with the reported price reflecting the weighted average. The filing states the reporting person will provide full trade detail upon request.
VIAVI Solutions Inc. (VIAV) reported an insider transaction on a Form 4. An officer (SVP General Manager OSP) sold 9,765 shares of common stock on 11/03/2025 at $17.45 per share. Following the sale, the officer directly beneficially owned 61,820 shares. The filing notes that the balance reflects an administrative adjustment.
VIAVI Solutions (VIAV) reported an insider transaction by its EVP, Chief Marketing & Strategy Officer. On 11/03/2025, the officer sold 12,617 shares of common stock at a weighted average price of $17.41, executed in multiple trades ranging from $17.40 to $17.43. Following the sale, the reporting person beneficially owns 28,044 shares. The filing notes the balance reflects an administrative adjustment.
Viavi Solutions (VIAV): Director insider sale disclosed. On 11/03/2025, a director sold 40,363 shares of common stock at $17.25 and 13,570 shares at $17.34. Following these transactions, the reporting person beneficially owns 125,151 shares, held directly. A footnote states the balance reflects an administrative adjustment.
Viavi Solutions (VIAV): An officer reported an open-market sale. The SVP, General Counsel & Secretary sold 11,148 shares of common stock on 11/03/2025 at a weighted average price of $17.29, with individual trades executed between $17.29 and $17.32.
Following the transaction, the reporting person beneficially owns 73,450 shares, held directly. The filing notes availability of full trade detail upon request.
Viavi Solutions (VIAV) reported its quarterly results for the period ended September 27, 2025. Total net revenue was $299.1 million versus $238.2 million a year ago, driven by higher product revenue. Operating income was $7.6 million compared with $11.5 million last year.
The company recorded a net loss of $21.4 million, primarily reflecting a $19.0 million income tax provision, including a revaluation of German deferred tax assets, and a $3.8 million loss on convertible note extinguishment. Cash from operations improved to $31.0 million; cash and cash equivalents were $543.8 million.
Viavi issued $250.0 million of 0.625% senior convertible notes due 2031, exchanged a portion of its 2026 notes, and repurchased 2.7 million shares for $30.0 million. Deferred revenue ended at $91.1 million, and remaining performance obligations were $352.6 million, with about 91% expected to be recognized within 12 months. Contingent consideration liabilities related to recent PNT acquisitions totaled $128.3 million.
Viavi Solutions Inc. (VIAV) filed an 8-K announcing it has reported preliminary results for its fiscal first quarter ended September 27, 2025. The company furnished a press release titled “VIAVI Announces First Quarter Fiscal 2026 Results,” attached as Exhibit 99.1 and dated October 29, 2025.
The company states that the information under Item 2.02 and Exhibit 99.1 is furnished, not filed, under the Exchange Act, is not subject to Section 18 liabilities, and is not incorporated by reference into other filings except as specifically referenced.